These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 36560545)

  • 1. Stimulated Reporting of Adverse Events Following Immunization with COVID-19 Vaccines.
    Jhaj R; Chaudhary D; Shukla AK; Yadav J
    Vaccines (Basel); 2022 Dec; 10(12):. PubMed ID: 36560545
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adverse events following ChAdOx1 nCoV-19 Vaccine (COVISHIELD) amongst health care workers: A prospective observational study.
    Kamal D; Thakur V; Nath N; Malhotra T; Gupta A; Batlish R
    Med J Armed Forces India; 2021 Jul; 77(Suppl 2):S283-S288. PubMed ID: 34334895
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adverse Events Following COVID-19 Vaccination in Selected Apartments in Bangalore, India.
    Chakraborty A; Reval N; Kamath L
    Cureus; 2022 Feb; 14(2):e21809. PubMed ID: 35291520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adverse events following immunization of COVID-19 (Covaxin) vaccine at a tertiary care center of India.
    Parida SP; Sahu DP; Singh AK; Alekhya G; Subba SH; Mishra A; Padhy BM; Patro BK
    J Med Virol; 2022 Jun; 94(6):2453-2459. PubMed ID: 35149993
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Canadian vaccine safety surveillance reports following immunization with seasonal influenza vaccines, 2021-2022.
    Giang E; Xu Y; Naganathan T; Abraham N; Bawolak MT; Salim BS; Weeks A; Shaw A; Ogunnaike-Cooke S
    Can Commun Dis Rep; 2024 Jan; 50(1-2):16-24. PubMed ID: 38655243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adverse effects after first and second dose of covishield and covaxin: A longitudinal study.
    Mittal A; Jain B; Varshney AM; Garg G; Sachan D; Singh RB
    J Family Med Prim Care; 2022 Nov; 11(11):7339-7345. PubMed ID: 36993127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaccines Safety in Children and in General Population: A Pharmacovigilance Study on Adverse Events Following Anti-Infective Vaccination in Italy.
    Lombardi N; Crescioli G; Bettiol A; Tuccori M; Rossi M; Bonaiuti R; Ravaldi C; Levi M; Mugelli A; Ricci S; Lippi F; Azzari C; Bonanni P; Vannacci A
    Front Pharmacol; 2019; 10():948. PubMed ID: 31543816
    [No Abstract]   [Full Text] [Related]  

  • 8. Adverse events following immunisation (AEFI) of COVISHIELD vaccination among healthcare workers in Ghana.
    Marfoh K; Samba A; Okyere E; Acheampong F; Owusu E; Darko DNA; Zakariah J; Mensa H; Aidoo E; Mohammed Y
    BMJ Open; 2023 Jun; 13(6):e061643. PubMed ID: 37380201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surveillance on Adverse Events Following COVISHIELD (ChAdOx1 nCoV-19) vaccination in Goa, India: An Observational Study.
    Jose D; Dhupdale N; Cacodcar JA; Kamat U
    Curr Drug Saf; 2023; 18(4):516-527. PubMed ID: 35927820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Imprecision in vaccine adverse event reporting and a methodological analysis of reporting systems to improve pharmacovigilance and public health.
    Inokuma Y; Kneller R
    Eur J Clin Pharmacol; 2023 Jul; 79(7):989-1002. PubMed ID: 37249640
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adverse Events Following COVISHIELD and VERO CELL Vaccination Campaigns Against COVID-19.
    Adhikari S; Maharjan J; Bhattarai S; Kunwar K; Agrawal S; Dangal RK; Chapagain RH; Bista TB; Bhattarai S
    J Nepal Health Res Counc; 2024 Mar; 21(4):651-658. PubMed ID: 38616598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. COVID-19 Vaccines Programs: adverse events following immunization (AEFI) among medical Clerkship Student in Jember, Indonesia.
    Supangat ; Sakinah EN; Nugraha MY; Qodar TS; Mulyono BW; Tohari AI
    BMC Pharmacol Toxicol; 2021 Oct; 22(1):58. PubMed ID: 34641944
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Maternal, fetal and neonatal outcomes among pregnant women receiving COVID-19 vaccination: The preg-co-vax study.
    Mascolo A; di Mauro G; Fraenza F; Gaio M; Zinzi A; Pentella C; Rossi F; Capuano A; Sportiello L
    Front Immunol; 2022; 13():965171. PubMed ID: 36263025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adverse events following immunization of COVID-19 vaccine among children aged 6-11 years.
    Puspitarani F; Sitaresmi MN; Ahmad RA
    Front Public Health; 2022; 10():999354. PubMed ID: 36388348
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaccine Safety and Surveillance for Adverse Events Following Immunization (AEFI) in India.
    Joshi J; Das MK; Polpakara D; Aneja S; Agarwal M; Arora NK
    Indian J Pediatr; 2018 Feb; 85(2):139-148. PubMed ID: 29170922
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A 1-year analysis of adverse events following COVID-19 vaccination in Lebanon: a retrospective study.
    Zeitoun A; Hallit S; Chehade S; Ibrahim A; Helali M; Allam C; Karam R
    J Pharm Policy Pract; 2023 Feb; 16(1):24. PubMed ID: 36810279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of 'SAEFVIC', A Pharmacovigilance Surveillance Scheme for the Spontaneous Reporting of Adverse Events Following Immunisation in Victoria, Australia.
    Clothier HJ; Crawford NW; Russell M; Kelly H; Buttery JP
    Drug Saf; 2017 Jun; 40(6):483-495. PubMed ID: 28342074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. National safety monitoring of vaccines from the Canadian Adverse Events Following Immunization Surveillance System (CAEFISS), 2018-2019.
    El Jaouhari M; Johnson K; Anyoti H; Xu Y; Wells C; Weeks A; Yeung A; Shaw A; Ogunnaike-Cooke S
    Can Commun Dis Rep; 2024 Jan; 50(1-2):49-57. PubMed ID: 38655246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adverse events following immunisation of COVID-19 vaccine among health care workers in the first phase of vaccination.
    Rahmat H; Leelavathi M; Wan Ismail WF
    Med J Malaysia; 2022 Nov; 77(6):637-642. PubMed ID: 36448378
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serious adverse event following immunization and thromboembolic events associated with COVID19 vaccination: An analysis of nationwide causality assessment from India.
    Gandhi AP; Venkatesh U; Murali N
    Indian Heart J; 2023; 75(2):139-144. PubMed ID: 36863611
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.